Clinical Trial Update: Arimidex Therapy Compliance Electronic Monitoring System

View source ↗

Summary

Clinical trial update on Arimidex (anastrozole) evaluating a therapy compliance electronic monitoring system in breast cancer. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED